$72.81
Live
0.76%
Downside
Day's Volatility :2.09%
Upside
1.34%
35.23%
Downside
52 Weeks Volatility :36.1%
Upside
1.34%
Period | Solventum Corp | S&P500 |
---|---|---|
3 Months | 36.12% | 6.5% |
6 Months | 18.7% | 18.1% |
1 Year | 6.63% | 38.8% |
3 Years | 6.63% | 28.9% |
Market Capitalization | 10.8B |
Wall Street Target Price | 69.67 |
Profit Margin | 15.73% |
Operating Margin TTM | 18.9% |
Return On Assets TTM | 7.66% |
Return On Equity TTM | 16.55% |
Revenue TTM | 8.2B |
Revenue Per Share TTM | 47.49 |
Quarterly Revenue Growth YOY | 0.2% |
Gross Profit TTM | 0.0 |
EBITDA | 2.3B |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | -0.19 |
EPS Estimate Current Year | 6.26 |
EPS Estimate Next Year | 5.84 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Downside of 4.31%
Sell
Neutral
Buy
Solventum Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Solventum Corp | 5.08% | 18.7% | 6.63% | 6.63% | 6.63% |
Tempus Ai | -10.87% | 22.58% | 22.58% | 22.58% | 22.58% |
Veeva Systems Inc. | 4.87% | 11.18% | 13.42% | -31.95% | 52.57% |
Ge Healthcare Technologies Inc. | 0.51% | 8.34% | 42.74% | 51.0% | 51.0% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Tempus Ai | NA | NA | NA | -2.41 | 0.0 | 0.0 | NA | 0.64 |
Veeva Systems Inc. | 57.72 | 57.72 | 1.25 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 26.25 | 26.25 | 2.37 | 4.25 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Solventum Corp | Hold | $10.8B | 6.63% | NA | 15.73% |
Tempus Ai | NA | $7.9B | 22.58% | NA | -121.04% |
Veeva Systems Inc. | Buy | $35.1B | 52.57% | 57.72 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $41.7B | 51.0% | 26.25 | 8.1% |
Insights on Solventum Corp
Revenue is up for the last 2 quarters, 2.01B → 2.08B (in $), with an average increase of 3.1% per quarter
Netprofit is down for the last 2 quarters, 237.0M → 89.0M (in $), with an average decrease of 62.5% per quarter
Solventum Corp’s price-to-earnings ratio stands at None
Read MoreOrganization | Solventum Corp |
Employees | 0 |
CEO | Mr. Bryan C. Hanson |
Industry | Miscellaneous |
Mid-cap Value Etf Vanguard
$72.81
-1.18%
Airbnb
$72.81
-1.18%
Ishares Core Dividend Growth Etf
$72.81
-1.18%
IHS Markit Ltd
$72.81
-1.18%
Silver Trust Etf Ishares
$72.81
-1.18%
Russell 1000 Index Ishares
$72.81
-1.18%
Evergy, Inc
$72.81
-1.18%
Affirm Holdings Inc
$72.81
-1.18%
Microsectors Energy 3x Inverse Leveraged Notes Due January 29 2043
$72.81
-1.18%